Literature DB >> 24811252

Is tocilizumab safe in Kaposi sarcoma? A complex association among rheumatoid arthritis, psoriasis, and Kaposi sarcoma.

Alice Verdelli1, Diletta Bonciani, Veronica Bonciolini, Marzia Caproni.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24811252     DOI： 10.1007/s40261-014-0200-7

Source DB:  PubMed          Journal:  Clin Drug Investig        ISSN： 1173-2563            Impact factor:   2.859


× No keyword cloud information.
  9 in total

1.  Psoriasis onset with tocilizumab treatment for rheumatoid arthritis.

Authors:  Daniel Wendling; Hélène Letho-Gyselinck; Xavier Guillot; Clément Prati
Journal:  J Rheumatol       Date:  2012-03       Impact factor: 4.666

2.  Onset of psoriasis following treatment with tocilizumab.

Authors:  S Laurent; J-M Le Parc; T Clérici; M Bréban; E Mahé
Journal:  Br J Dermatol       Date:  2010-11-04       Impact factor: 9.302

3.  Psoriasis onset with tocilizumab.

Authors:  Anne Grasland; Emmanuel Mahé; Edouard Raynaud; Isabelle Mahé
Journal:  Joint Bone Spine       Date:  2013-06-02       Impact factor: 4.929

4.  Human and viral interleukin-6 and other cytokines in Kaposi sarcoma herpesvirus-associated multicentric Castleman disease.

Authors:  Mark N Polizzotto; Thomas S Uldrick; Victoria Wang; Karen Aleman; Kathleen M Wyvill; Vickie Marshall; Stefania Pittaluga; Deirdre O'Mahony; Denise Whitby; Giovanna Tosato; Seth M Steinberg; Richard F Little; Robert Yarchoan
Journal:  Blood       Date:  2013-10-30       Impact factor: 22.113

Review 5.  Viral interleukin-6: role in Kaposi's sarcoma-associated herpesvirus: associated malignancies.

Authors:  Shuhei Sakakibara; Giovanna Tosato
Journal:  J Interferon Cytokine Res       Date:  2011-07-18       Impact factor: 2.607

6.  Detection of viral interleukin-6 in Kaposi sarcoma-associated herpesvirus-linked disorders.

Authors:  Y Aoki; R Yarchoan; K Wyvill; S Okamoto ; R F Little; G Tosato
Journal:  Blood       Date:  2001-04-01       Impact factor: 22.113

Review 7.  Kaposi sarcoma associated herpesvirus pathogenesis (KSHV)--an update.

Authors:  Dirk P Dittmer; Blossom Damania
Journal:  Curr Opin Virol       Date:  2013-06-13       Impact factor: 7.090

8.  Clinical Manifestations of Kaposi Sarcoma Herpesvirus Lytic Activation: Multicentric Castleman Disease (KSHV-MCD) and the KSHV Inflammatory Cytokine Syndrome.

Authors:  Mark N Polizzotto; Thomas S Uldrick; Duosha Hu; Robert Yarchoan
Journal:  Front Microbiol       Date:  2012-03-02       Impact factor: 5.640

9.  Tocilizumab monotherapy in a patient with rheumatoid arthritis and iatrogenic Kaposi sarcoma.

Authors:  Francesca Ingegnoli; Athanasia Tourlaki; Roberta Gualtierotti
Journal:  Clin Drug Investig       Date:  2014-02       Impact factor: 3.580
  9 in total
  2 in total

1.  Authors' reply to Verdelli et al.: there is no knowledge without experience.

Authors:  Francesca Ingegnoli; Athanasia Tourlaki; Roberta Gualtierotti
Journal:  Clin Drug Investig       Date:  2014-06       Impact factor: 2.859

2.  Hidden Pictures of Kaposi's Sarcoma in Psoriatic Lesions: A Diagnostic Challenge.

Authors:  Jisook Yoo; Mingyul Jo; Min-Soo Kim; Kwang-Hyun Choi; Hyang-Joon Park; Mihn-Sook Jue
Journal:  Ann Dermatol       Date:  2016-11-23       Impact factor: 1.444
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.